logo

BXP

BXP·NYSE
--
--(--)
--
--(--)
1.74 / 10
Underperform

Fundamental health is rated poor (1.7/10). Key concerns include an Asset-MV value of -0.5007 (Group 3), Profit-MV of 0.6320 (Group 1), and a payout ratio well above 100%. Historical back-tests show negative monthly returns for most factors, underscoring weak intrinsic quality. Constructive elements such as Current liabilities / Total liabilities (%) in Group 1 offer limited relief, but the overall case is unfavorable.

Fundamental(1.74)SentimentTechnical

Analysis Checks(6/10)

Annualized return on equity (%)
Value5.24
Score3/3
Weight-0.26%
1M Return0.03%
Current liabilities / Total liabilities (%)
Value53.71
Score3/3
Weight8.60%
1M Return-1.00%
Profit-MV
Value0.63
Score1/3
Weight25.55%
1M Return-3.53%
Net income-Revenue
Value1.02
Score1/3
Weight31.72%
1M Return-15.79%
Total profit (YoY growth rate %)
Value356.12
Score1/3
Weight14.95%
1M Return-1.72%
Income tax / Total profit (%)
Value20.85
Score2/3
Weight13.58%
1M Return-1.62%
Cash-UP
Value-0.03
Score3/3
Weight-4.03%
1M Return0.33%
ROE (diluted) (%)
Value5.38
Score3/3
Weight-0.26%
1M Return0.03%
Asset-MV
Value-0.50
Score1/3
Weight-0.55%
1M Return0.05%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight10.70%
1M Return-1.19%
Is BXP undervalued or overvalued?
  • BXP scores 1.74/10 on fundamentals and holds a Premium valuation at present. Backed by its 3.54% ROE, 11.03% net margin, 37.07 P/E ratio, 1.33 P/B ratio, and 1844.44% earnings growth, these metrics solidify its Underperform investment rating.